Beihai Gofar Chuanshan Biological Co., Ltd.
SSE:600538.SS
5.56 (CNY) • At close May 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 340.468 | 369.155 | 459.684 | 424.717 | 267.7 | 251.154 | 224.524 | 434.488 | 455.409 | 506.408 | 415.412 | 452.415 | 542.983 | 528.703 | 363.299 | 241.319 | 325.966 | 789.653 | 539.192 | 461.998 | 373.376 | 231.164 | 99.01 | 94.057 | 81.444 | 64.182 |
| Cost of Revenue
| 253.191 | 279.455 | 331.47 | 315.181 | 200.633 | 204.204 | 180.143 | 355.225 | 406.194 | 422.208 | 369.883 | 382.19 | 461.189 | 455.53 | 317.231 | 210.551 | 295.325 | 611.017 | 419.129 | 328.716 | 256.525 | 128.191 | 38.097 | 34.478 | 28.97 | 20.538 |
| Gross Profit
| 87.277 | 89.699 | 128.214 | 109.536 | 67.067 | 46.95 | 44.381 | 79.263 | 49.215 | 84.2 | 45.53 | 70.225 | 81.794 | 73.172 | 46.068 | 30.768 | 30.641 | 178.636 | 120.063 | 133.282 | 116.851 | 102.973 | 60.913 | 59.579 | 52.474 | 43.644 |
| Gross Profit Ratio
| 0.256 | 0.243 | 0.279 | 0.258 | 0.251 | 0.187 | 0.198 | 0.182 | 0.108 | 0.166 | 0.11 | 0.155 | 0.151 | 0.138 | 0.127 | 0.127 | 0.094 | 0.226 | 0.223 | 0.288 | 0.313 | 0.445 | 0.615 | 0.633 | 0.644 | 0.68 |
| Reseach & Development Expenses
| 8.223 | 11.709 | 8.38 | 9.144 | 0.05 | 0.076 | 0.25 | 0.949 | 1.913 | 1.065 | 1.109 | 4.104 | 3.206 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 20.626 | 23.987 | 17.094 | 16.968 | 12.487 | 9.895 | 11.09 | 16.765 | 25.435 | 16.256 | 24.016 | 17.486 | 18.859 | 16.134 | 18.49 | 41.609 | 38.511 | 45.96 | 56.399 | 48.905 | 37.404 | 37.671 | 13.429 | 13.225 | 13.275 | 11.667 |
| Selling & Marketing Expenses
| 13.001 | 14.907 | 34.872 | 38.525 | 30.037 | 28.508 | 34.639 | 35.398 | 38.219 | 32.2 | 34.058 | 35.528 | 47.282 | 39.97 | 29.484 | 27.319 | 25.465 | 72.866 | 42.142 | 33.053 | 36.375 | 26.234 | 18.062 | 14.471 | 9.499 | 6.456 |
| SG&A
| 33.627 | 56.963 | 51.966 | 55.494 | 42.523 | 38.403 | 45.729 | 52.163 | 63.654 | 48.456 | 58.074 | 53.014 | 66.141 | 56.104 | 47.974 | 68.928 | 63.976 | 118.826 | 98.541 | 81.958 | 73.779 | 63.905 | 31.491 | 27.696 | 22.774 | 18.122 |
| Other Expenses
| 137.116 | 98.79 | 35.398 | 28.735 | 19.3 | 18.52 | -0.46 | -0.547 | 1.838 | 2.701 | 2.044 | 36.759 | 0.6 | 5.449 | 80.042 | 6.542 | -7.983 | 6.588 | 8.894 | 10.69 | 5.847 | 0.547 | 0.131 | 2.93 | -0.155 | -0.234 |
| Operating Expenses
| 178.966 | 167.462 | 95.743 | 93.372 | 61.874 | 56.999 | 70.475 | 90.003 | 97.449 | 79.932 | 88.493 | 79.899 | 102.338 | 87.464 | 87.065 | 72.979 | 69.748 | 124.962 | 99.92 | 83.823 | 75.898 | 65.922 | 33.984 | 30.561 | 25.752 | 21.19 |
| Operating Income
| -91.689 | -77.763 | 42.285 | 20.47 | 8.823 | 1.212 | -20.704 | 4.385 | -50.214 | 6.985 | -57.276 | -22.875 | -85.063 | -38.012 | -62.712 | -145.1 | -167.604 | 24.606 | -16.169 | 23.835 | 25.055 | 32.354 | 23.957 | 25.852 | 23.988 | 19.963 |
| Operating Income Ratio
| -0.269 | -0.211 | 0.092 | 0.048 | 0.033 | 0.005 | -0.092 | 0.01 | -0.11 | 0.014 | -0.138 | -0.051 | -0.157 | -0.072 | -0.173 | -0.601 | -0.514 | 0.031 | -0.03 | 0.052 | 0.067 | 0.14 | 0.242 | 0.275 | 0.295 | 0.311 |
| Total Other Income Expenses Net
| -0.295 | 0.198 | -0.174 | 0.63 | 0.749 | 0.844 | -0.46 | -0.547 | 1.691 | 2.627 | -7.311 | 36.503 | -45.113 | -5.703 | 79.941 | -82.663 | -141.237 | -21.641 | -40.698 | -28.076 | -24.67 | 0.318 | 0.125 | -0.236 | -0.153 | -0.233 |
| Income Before Tax
| -91.983 | -77.565 | 42.111 | 15.789 | 9.572 | 10.412 | -21.164 | 3.838 | -48.523 | 9.613 | -64.588 | 13.628 | -101.139 | -32.661 | 17.229 | -141.52 | -176.637 | 31.459 | -10.955 | 27.954 | 23.593 | 32.672 | 24.083 | 25.616 | 23.836 | 19.73 |
| Income Before Tax Ratio
| -0.27 | -0.21 | 0.092 | 0.037 | 0.036 | 0.041 | -0.094 | 0.009 | -0.107 | 0.019 | -0.155 | 0.03 | -0.186 | -0.062 | 0.047 | -0.586 | -0.542 | 0.04 | -0.02 | 0.061 | 0.063 | 0.141 | 0.243 | 0.272 | 0.293 | 0.307 |
| Income Tax Expense
| -0.07 | 3.594 | 5.445 | 5.862 | 6.371 | 4.639 | 0.447 | 1.483 | 0.528 | 1.363 | 0.206 | 2.283 | 3.283 | 1.165 | 0.159 | -0.912 | 1.702 | 12.844 | 8.162 | 2.721 | 2.328 | 2.382 | 0.519 | 0.827 | 8.169 | 3.522 |
| Net Income
| -93.85 | -82.308 | 34.842 | 10.487 | 3.201 | 5.773 | -21.611 | 8.851 | -31.862 | 4.053 | -49.196 | 10.689 | -109.567 | -39.042 | 16.403 | -138.429 | -176.71 | 3.035 | -30.215 | 17.742 | 16.207 | 28.094 | 23.694 | 24.594 | 15.608 | 16.218 |
| Net Income Ratio
| -0.276 | -0.223 | 0.076 | 0.025 | 0.012 | 0.023 | -0.096 | 0.02 | -0.07 | 0.008 | -0.118 | 0.024 | -0.202 | -0.074 | 0.045 | -0.574 | -0.542 | 0.004 | -0.056 | 0.038 | 0.043 | 0.122 | 0.239 | 0.261 | 0.192 | 0.253 |
| EPS
| -0.18 | -0.16 | 0.067 | 0.02 | 0.006 | 0.012 | -0.05 | 0.02 | -0.07 | 0.01 | -0.13 | 0.04 | -0.39 | -0.14 | 0.06 | -0.5 | -0.63 | 0.01 | -0.11 | 0.064 | 0.058 | 0.1 | 0.14 | 0.091 | 0.057 | 0.06 |
| EPS Diluted
| -0.18 | -0.16 | 0.067 | 0.02 | 0.006 | 0.012 | -0.05 | 0.02 | -0.07 | 0.01 | -0.13 | 0.04 | -0.39 | -0.14 | 0.06 | -0.5 | -0.63 | 0.01 | -0.11 | 0.064 | 0.058 | 0.1 | 0.14 | 0.091 | 0.057 | 0.06 |
| EBITDA
| -71.785 | -52.956 | 58.69 | 31.363 | 24.286 | 28.627 | -5.227 | 39.518 | -11.279 | 40.004 | -26.12 | 42.506 | -62.291 | 2.493 | 92.12 | -28.243 | 8.444 | 92.713 | 58.851 | 88.047 | 61.417 | 46.961 | 32.768 | 33.977 | 26.705 | 22.454 |
| EBITDA Ratio
| -0.211 | -0.143 | 0.128 | 0.074 | 0.091 | 0.114 | -0.023 | 0.091 | -0.025 | 0.079 | -0.063 | 0.094 | -0.115 | 0.005 | 0.254 | -0.117 | 0.026 | 0.117 | 0.109 | 0.191 | 0.164 | 0.203 | 0.331 | 0.361 | 0.328 | 0.35 |